{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:44:59Z","timestamp":1761515099426,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.4158\/ep.6.6.435","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T23:37:39Z","timestamp":1365205059000},"page":"435-441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Hyperhomocysteinemia In Type 2 Diabetes Mellitus: Cardiovascular Risk Factors And Effect Of Treatment With Folic Acid And Pyridoxine"],"prefix":"10.1016","volume":"6","author":[{"given":"Bantwal Suresh","family":"Baliga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammy","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis M.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian A.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.6.6.435_bb0010","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial","volume":"16","author":"Stamler","year":"1993","journal-title":"Diabetes Care"},{"key":"10.4158\/EP.6.6.435_bb0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0026-0495(96)90211-5","article-title":"Hyper- homocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease","volume":"45","author":"Munshi","year":"1996","journal-title":"Metabolism"},{"key":"10.4158\/EP.6.6.435_bb0020","series-title":"Homocysteine Metabolism: From Basic Science to Clinical Medicine","first-page":"205","article-title":"Plasma homocysteine and its relationship to cardiovascular risk factors in a Japanese population","author":"Araki","year":"1998"},{"key":"10.4158\/EP.6.6.435_bb0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.18.1.133","volume":"18","author":"Duna","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.4158\/EP.6.6.435_bb0030","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2337\/diacare.22.3.484","article-title":"Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes","volume":"22","author":"Okada","year":"1999","journal-title":"Diabetes Care"},{"key":"10.4158\/EP.6.6.435_bb0035","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1523-1755.1999.00256.x","article-title":"Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria","volume":"55","author":"Stehouwer","year":"1999","journal-title":"Kidney Int"},{"key":"10.4158\/EP.6.6.435_bb0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-2007-994932","article-title":"Hyperhomocysteinemia and thrombosis","volume":"25","author":"Guba","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.4158\/EP.6.6.435_bb0045","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.1995.03530190040032","article-title":"Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study","volume":"274","author":"Nygard","year":"1995","journal-title":"JAMA"},{"key":"10.4158\/EP.6.6.435_bb0050","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","article-title":"Homocysteine and atherothrom- bosis","volume":"338","author":"Welch","year":"1998","journal-title":"NEngl J Med"},{"key":"10.4158\/EP.6.6.435_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00019501-199901000-00004","article-title":"Type 2 diabetes: one disease, multiple cardiovascular risk factors","volume":"10","author":"Calles-Escandon","year":"1999","journal-title":"Coron Artery Dis"},{"key":"10.4158\/EP.6.6.435_bb0060","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1055\/s-0037-1615353","article-title":"Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction\u2014the PRIME Study: Prospective Epidemiological Study of Myocardial Infarction","volume":"80","author":"Scarabin","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.4158\/EP.6.6.435_bb0065","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/ajcp\/106.6.709","article-title":"Hyperhomocysteinemia: an emerging and important risk factor for thromboembolic and cardiovascular disease [published errata appear in Am J Clin Pathol. 1997;107:621 and 1997;107:715]","volume":"106","author":"Guba","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.4158\/EP.6.6.435_bb0070","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1210\/edrv.20.5.0381","article-title":"Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis","volume":"20","author":"Fonseca","year":"1999","journal-title":"Endocr Rev"},{"key":"10.4158\/EP.6.6.435_bb0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1056-8727(97)00109-8","article-title":"Effect of troglitazone on fibrinolysis and activated coagulation in patients with non-insulin-dependent diabetes mellitus","volume":"12","author":"Fonseca","year":"1998","journal-title":"J Diabetes Complications"},{"key":"10.4158\/EP.6.6.435_bb0080","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.2337\/diabetes.47.12.1967","article-title":"Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat","volume":"47","author":"Jacobs","year":"1998","journal-title":"Diabetes"},{"key":"10.4158\/EP.6.6.435_bb0085","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/meta.2000.6256","article-title":"Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat","volume":"49","author":"Fonseca","year":"2000","journal-title":"Metabolism"},{"key":"10.4158\/EP.6.6.435_bb0090","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2337\/diacare.21.5.841","article-title":"Hyper- homocyst(e)inemia and endothelial dysfunction in IDDM [corrected and republished article originally printed in Diabetes Care. 1997;20:1880-1886]","volume":"21","author":"Hofmann","year":"1998","journal-title":"Diabetes Care"},{"key":"10.4158\/EP.6.6.435_bb0095","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s001250050969","article-title":"Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?","volume":"41","author":"Chico","year":"1998","journal-title":"Diabetologia"},{"key":"10.4158\/EP.6.6.435_bb0100","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0026-0495(98)90344-4","article-title":"Fasting and post-methionine load homocyst(e)ine values are correlated with microalbuminuria and could contribute to worsening vascular damage in non-insulin-dependent diabetes mellitus patients","volume":"47","author":"Lanfredini","year":"1998","journal-title":"Metabolism"},{"key":"10.4158\/EP.6.6.435_bb0105","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0895-7061(98)00125-3","article-title":"Plasma homocysteine and folate are related to arterial blood pressure in type 2 diabetes mellitus","volume":"11","author":"Fiorina","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.4158\/EP.6.6.435_bb0110","first-page":"125","article-title":"Fasting and post-methionine load homocysteine levels in NIDDM: determinants and correlations with retinopathy, albuminuria, and cardiovascular disease","volume":"22","author":"Smulders","year":"1999","journal-title":"Metabolism"},{"key":"10.4158\/EP.6.6.435_bb0115","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1055\/s-0038-1665406","article-title":"Endothelial marker proteins in hyperhomocysteinemia","volume":"78","author":"de Jong","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.4158\/EP.6.6.435_bb0120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2362.1995.tb01545.x","article-title":"Hyperhomocysteinemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease","volume":"25","author":"van den Berg","year":"1995","journal-title":"Eur J Clin Invest"},{"issue":"4 Suppl","key":"10.4158\/EP.6.6.435_bb0125","first-page":"285S","article-title":"Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis","volume":"126","author":"Harpel","year":"1996","journal-title":"J Nutr"},{"key":"10.4158\/EP.6.6.435_bb0130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0049-3848(93)90153-F","article-title":"Elevated total plasma homocysteine, a risk factor for thrombosis: relation to coagulation and fibrinolytic parameters","volume":"70","author":"Bienvenu","year":"1993","journal-title":"Thromb Res"},{"key":"10.4158\/EP.6.6.435_bb0135","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0022-3476(83)80247-9","article-title":"Diet-responsive proconvertin (factor VII) deficiency in homocystinuria","volume":"102","author":"Munnich","year":"1983","journal-title":"J Pediatr"},{"key":"10.4158\/EP.6.6.435_bb0140","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(75)91870-X","article-title":"Antithrombin activity in homocystinuria [letter]","volume":"1","author":"Giannini","year":"1975","journal-title":"Lancet"},{"key":"10.4158\/EP.6.6.435_bb0145","first-page":"125","article-title":"Homocystinuria: clinical and pathologic review, with emphasis on thrombotic features, including pulmonary artery thrombosis","volume":"17","author":"Lieberman","year":"1993","journal-title":"Perspect Pediatr Pathol"},{"key":"10.4158\/EP.6.6.435_bb0150","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/00001721-199412000-00002","article-title":"Coagulation factors and markers of activation of coagulation in homo- cystinuria (HOCY): a study in two siblings","volume":"5","author":"Schienle","year":"1994","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.4158\/EP.6.6.435_bb0155","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0026-0495(98)90031-2","article-title":"Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects","volume":"47","author":"Fonseca","year":"1998","journal-title":"Metabolism"},{"key":"10.4158\/EP.6.6.435_bb0160","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/jn\/124.10.1927","article-title":"Vitamin requirements for the treatment of hyperhomocysteinemia in humans","volume":"124","author":"Ubbink","year":"1994","journal-title":"J Nutr"},{"key":"10.4158\/EP.6.6.435_bb0165","series-title":"Homocysteine Metabolism: From Basic Science to Clinical Medicine","first-page":"93","article-title":"Vitamin status and hyperhomocysteinemia in a healthy population","author":"Ubbink","year":"1998"},{"key":"10.4158\/EP.6.6.435_bb0170","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ajcn\/55.6.1154","article-title":"Effect of vitamin B-6 deficiency on fasting plasma homocysteine concentrations","volume":"55","author":"Miller","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.4158\/EP.6.6.435_bb0175","first-page":"111","article-title":"Treatment of mild hyperhomocysteinemia. In: Graham I, Refsum H, Rosenburg I, Ueland PM, eds","volume":"55","author":"Boers","year":"1998","journal-title":"Homocysteine Metabolism: From Basic Science to Clinical Medicine"},{"key":"10.4158\/EP.6.6.435_bb0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0021-9150(90)90058-Q","article-title":"Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease: effects of pyridoxine and folic acid treatment","volume":"81","author":"Brattstr\u00f6m","year":"1990","journal-title":"Atherosclerosis"},{"key":"10.4158\/EP.6.6.435_bb0185","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0741-5214(94)90230-5","article-title":"Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia","volume":"20","author":"van den Berg","year":"1994","journal-title":"J Vasc Surg"},{"key":"10.4158\/EP.6.6.435_bb0190","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2796.1995.tb01190.x","article-title":"Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid","volume":"237","author":"Landgren","year":"1995","journal-title":"J Intern Med"},{"key":"10.4158\/EP.6.6.435_bb0195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0021-9150(93)90258-V","article-title":"Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment","volume":"103","author":"Araki","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.4158\/EP.6.6.435_bb0200","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/bmj.316.7135.894","article-title":"Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials","volume":"316","year":"1998","journal-title":"BMJ"},{"key":"10.4158\/EP.6.6.435_bb0205","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0021-9150(98)00273-1","article-title":"Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocys- teinaemia in patients with premature arterial disease and their relatives","volume":"143","author":"van der Griend","year":"1999","journal-title":"Atherosclerosis"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20411127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20411127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/QDFC68G55K874YB2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:40:26Z","timestamp":1761514826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20411127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["S1530891X20411127"],"URL":"https:\/\/doi.org\/10.4158\/ep.6.6.435","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2000,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperhomocysteinemia In Type 2 Diabetes Mellitus: Cardiovascular Risk Factors And Effect Of Treatment With Folic Acid And Pyridoxine","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.6.6.435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}